NO20004186L - Erythropoietin-liposomal dispersjon - Google Patents

Erythropoietin-liposomal dispersjon

Info

Publication number: NO20004186L
Authority: NO; Norway
Prior art keywords: erythropoietin; cholesterol; cholesterols; lecithin; liposome based
Prior art date: 1998-02-23

Application number

NO20004186A

Other languages

English (en)

Norwegian (no)

Other versions

NO20004186D0 (no

Inventor

Rainer Naff

Sandro Delmenico

Andre Wetter

Frank-Ulrich Floether

Original Assignee

Cilag Ag Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-23

Filing date

2000-08-22

Publication date

2000-08-22

2000-08-22 Application filed by Cilag Ag Int filed Critical Cilag Ag Int

2000-08-22 Publication of NO20004186D0 publication Critical patent/NO20004186D0/no

2000-08-22 Publication of NO20004186L publication Critical patent/NO20004186L/no

Links

239000006185 dispersion Substances 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 3
235000012000 cholesterol Nutrition 0.000 abstract 3
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 2
102000003951 Erythropoietin Human genes 0.000 abstract 2
108090000394 Erythropoietin Proteins 0.000 abstract 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
229940105423 erythropoietin Drugs 0.000 abstract 2
239000002502 liposome Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
102000008100 Human Serum Albumin Human genes 0.000 abstract 1
108091006905 Human Serum Albumin Proteins 0.000 abstract 1
239000002202 Polyethylene glycol Chemical class 0.000 abstract 1
150000001840 cholesterol esters Chemical class 0.000 abstract 1
150000001841 cholesterols Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
150000002334 glycols Chemical class 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
229940067606 lecithin Drugs 0.000 abstract 1
235000010445 lecithin Nutrition 0.000 abstract 1
239000000787 lecithin Substances 0.000 abstract 1
-1 lipid compound Chemical class 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
239000006201 parenteral dosage form Substances 0.000 abstract 1
239000008363 phosphate buffer Substances 0.000 abstract 1
229920001223 polyethylene glycol Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

NO20004186A 1998-02-23 2000-08-22 Erythropoietin-liposomal dispersjon NO20004186L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98103111A EP0937456B1 (en)	1998-02-23	1998-02-23	Erythropoietin liposomal dispersion
PCT/IB1999/000249 WO1999042085A1 (en)	1998-02-23	1999-02-12	Erythropoietin liposomal dispersion

Publications (2)

Publication Number	Publication Date
NO20004186D0 NO20004186D0 (no)	2000-08-22
NO20004186L true NO20004186L (no)	2000-08-22

Family

ID=8231466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004186A NO20004186L (no)	1998-02-23	2000-08-22	Erythropoietin-liposomal dispersjon

Country Status (23)

Country	Link
US (2)	US6645522B2 (pl)
EP (1)	EP0937456B1 (pl)
JP (1)	JP4613294B2 (pl)
KR (1)	KR100591871B1 (pl)
CN (1)	CN1184958C (pl)
AT (1)	ATE271376T1 (pl)
AU (1)	AU750481B2 (pl)
BR (1)	BR9908202A (pl)
CA (1)	CA2320072C (pl)
CZ (1)	CZ296415B6 (pl)
DE (1)	DE69825137T2 (pl)
DK (1)	DK0937456T3 (pl)
ES (1)	ES2224299T3 (pl)
HU (1)	HUP0101026A2 (pl)
IL (2)	IL137808A0 (pl)
NO (1)	NO20004186L (pl)
NZ (1)	NZ506429A (pl)
PL (1)	PL194502B1 (pl)
PT (1)	PT937456E (pl)
RU (1)	RU2218914C2 (pl)
SI (1)	SI0937456T1 (pl)
SK (1)	SK284036B6 (pl)
WO (1)	WO1999042085A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT937456E (pt) *	1998-02-23	2004-10-29	Cilag Ag Int	Dispersao lipossomal de eritropoietina
US7345019B1 (en) *	1999-04-13	2008-03-18	The Kenneth S. Warren Institute, Inc.	Modulation of excitable tissue function by peripherally administered erythropoietin
EP1111050B1 (de) *	1999-12-22	2007-03-14	Dade Behring Marburg GmbH	Lösungen von humanem Procalcitonin
US20030072737A1 (en)	2000-12-29	2003-04-17	Michael Brines	Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US7767643B2 (en)	2000-12-29	2010-08-03	The Kenneth S. Warren Institute, Inc.	Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
DE10219545A1 (de) *	2002-04-26	2003-11-06	Lang Florian	Regulation der Apoptose
WO2004022593A2 (en) *	2002-09-09	2004-03-18	Nautilus Biotech	Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
JP2004115397A (ja) *	2002-09-25	2004-04-15	Fuji Photo Film Co Ltd	血管疾患治療薬を含むリポソーム
BRPI0407276A (pt) *	2003-02-07	2006-01-31	Prometic Biosciences Inc	ácidos graxos, glicerìdeos e análogos com comprimento de cadeia médio, como estimulantes de eritropoiese
EP1647277A4 (en) *	2003-07-17	2011-09-21	Otsuka Pharma Co Ltd	LIPOSOME CONTAINING GLYCOSIDE
CN1897959A (zh) *	2003-09-29	2007-01-17	沃伦药品公司	用于治疗和预防脓毒病和粘连形成的组织保护细胞因子
EP1537876A1 (en) *	2003-12-01	2005-06-08	BioGeneriX AG	Erythropoietin solution formulation
US20080113015A1 (en) *	2004-05-24	2008-05-15	Polymun Scientific Immunbiologische Forschung Gmbh	Superloaded Liposomes for Drug Delivery
KR100684380B1 (ko)	2005-05-24	2007-02-20	한국화학연구원	빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법
US9119782B2 (en)	2006-03-20	2015-09-01	Mary P. McCourt	Drug delivery means
WO2008065372A2 (en)	2006-11-28	2008-06-05	Nautilus Biotech, S.A.	Modified erythropoietin polypeptides and uses thereof for treatment
US20100310636A1 (en) *	2007-05-09	2010-12-09	Gita Sharma	Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
US20100003322A1 (en) *	2008-07-03	2010-01-07	Lai Felix S	Enteric coated hydrophobic matrix formulation
US20110070294A1 (en) *	2009-09-23	2011-03-24	Javeri Indu	Methods for the Administration of Drugs Using Liposomes
CA2840339A1 (en) *	2010-06-23	2011-12-29	Brightside Innovations, Inc.	Lecithin carrier vesicles and methods of making the same
EA018472B1 (ru) *	2010-09-15	2013-08-30	Открытое Акционерное Общество "Протек"	Частицы, содержащие эритропоэтин, для лечения и профилактики неврологических и гематологических заболеваний и нарушений
JP2016513712A (ja)	2013-03-14	2016-05-16	ジェローム，ジェイ．シェンターク，	カイロミクロンへの分子の取り込みのためのコレストソーム小胞
CN103751214A (zh) *	2014-01-03	2014-04-30	广州市鼍龙生物技术开发有限公司	一种鳄鱼油纳米脂质体及其制备方法
EP3138556B1 (en) *	2014-04-30	2022-03-02	FUJIFILM Corporation	Method for producing liposomes
US11198831B2 (en)	2019-01-31	2021-12-14	Kvi Llc	Lubricant for a device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ210501A (en)	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS6197229A (ja) *	1984-10-18	1986-05-15	Chugai Pharmaceut Co Ltd	安定なエリトロポエチン製剤
AU598002B2 (en) *	1986-07-15	1990-06-14	Cilag Ltd.	Method of preparing single bilayered liposomes
JPH087219B2 (ja)	1992-04-27	1996-01-29	雪印乳業株式会社	リポソーム封入生理活性蛋白質の定量方法
JPH06228012A (ja)	1993-01-29	1994-08-16	Dai Ichi Seiyaku Co Ltd	リポソーム製剤
CA2120197A1 (en) *	1993-04-02	1994-10-03	Kenji Endo	Stable aqueous dispersions containing liposomes
ATE222752T1 (de) *	1993-10-06	2002-09-15	Amgen Inc	Stabile protein-phospholipid zusammensetzungen und verfahren
US5874075A (en) *	1993-10-06	1999-02-23	Amgen Inc.	Stable protein: phospholipid compositions and methods
US6214388B1 (en) *	1994-11-09	2001-04-10	The Regents Of The University Of California	Immunoliposomes that optimize internalization into target cells
JP3850468B2 (ja) *	1994-12-28	2006-11-29	中外製薬株式会社	エリスロポエチンのリポソーム製剤
US5858397A (en) *	1995-10-11	1999-01-12	University Of British Columbia	Liposomal formulations of mitoxantrone
PT937456E (pt) *	1998-02-23	2004-10-29	Cilag Ag Int	Dispersao lipossomal de eritropoietina

1998
- 1998-02-23 PT PT98103111T patent/PT937456E/pt unknown
- 1998-02-23 DK DK98103111T patent/DK0937456T3/da active
- 1998-02-23 SI SI9830684T patent/SI0937456T1/xx unknown
- 1998-02-23 AT AT98103111T patent/ATE271376T1/de active
- 1998-02-23 ES ES98103111T patent/ES2224299T3/es not_active Expired - Lifetime
- 1998-02-23 EP EP98103111A patent/EP0937456B1/en not_active Expired - Lifetime
- 1998-02-23 DE DE69825137T patent/DE69825137T2/de not_active Expired - Lifetime
1999
- 1999-02-12 BR BR9908202-0A patent/BR9908202A/pt not_active Application Discontinuation
- 1999-02-12 HU HU0101026A patent/HUP0101026A2/hu unknown
- 1999-02-12 KR KR1020007009202A patent/KR100591871B1/ko not_active Expired - Fee Related
- 1999-02-12 WO PCT/IB1999/000249 patent/WO1999042085A1/en not_active Ceased
- 1999-02-12 JP JP2000532102A patent/JP4613294B2/ja not_active Expired - Fee Related
- 1999-02-12 CN CNB998052590A patent/CN1184958C/zh not_active Expired - Fee Related
- 1999-02-12 IL IL13780899A patent/IL137808A0/xx active IP Right Grant
- 1999-02-12 PL PL99342514A patent/PL194502B1/pl unknown
- 1999-02-12 NZ NZ506429A patent/NZ506429A/xx not_active IP Right Cessation
- 1999-02-12 CZ CZ20002959A patent/CZ296415B6/cs not_active IP Right Cessation
- 1999-02-12 SK SK1222-2000A patent/SK284036B6/sk not_active IP Right Cessation
- 1999-02-12 RU RU2000124317/14A patent/RU2218914C2/ru not_active IP Right Cessation
- 1999-02-12 AU AU21808/99A patent/AU750481B2/en not_active Ceased
- 1999-02-12 CA CA002320072A patent/CA2320072C/en not_active Expired - Fee Related
- 1999-02-18 US US09/252,563 patent/US6645522B2/en not_active Expired - Lifetime
2000
- 2000-08-10 IL IL137808A patent/IL137808A/en not_active IP Right Cessation
- 2000-08-22 NO NO20004186A patent/NO20004186L/no not_active Application Discontinuation
2003
- 2003-09-10 US US10/659,097 patent/US20040052838A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999042085A1 (en)	1999-08-26
PL194502B1 (pl)	2007-06-29
IL137808A0 (en)	2001-10-31
PL342514A1 (en)	2001-06-18
JP2002503685A (ja)	2002-02-05
SK284036B6 (sk)	2004-08-03
ATE271376T1 (de)	2004-08-15
CZ296415B6 (cs)	2006-03-15
NO20004186D0 (no)	2000-08-22
US20040052838A1 (en)	2004-03-18
DE69825137D1 (de)	2004-08-26
CA2320072A1 (en)	1999-08-26
PT937456E (pt)	2004-10-29
HUP0101026A2 (hu)	2001-08-28
BR9908202A (pt)	2000-10-24
SI0937456T1 (en)	2004-12-31
NZ506429A (en)	2003-03-28
US6645522B2 (en)	2003-11-11
KR100591871B1 (ko)	2006-06-23
AU750481B2 (en)	2002-07-18
JP4613294B2 (ja)	2011-01-12
KR20010041152A (ko)	2001-05-15
EP0937456A1 (en)	1999-08-25
ES2224299T3 (es)	2005-03-01
CZ20002959A3 (cs)	2001-10-17
CA2320072C (en)	2009-04-07
CN1298296A (zh)	2001-06-06
RU2218914C2 (ru)	2003-12-20
AU2180899A (en)	1999-09-06
DE69825137T2 (de)	2005-07-21
IL137808A (en)	2007-07-24
CN1184958C (zh)	2005-01-19
DK0937456T3 (da)	2004-11-08
SK12222000A3 (sk)	2001-11-06
EP0937456B1 (en)	2004-07-21
US20020028236A1 (en)	2002-03-07

Legal Events

Date	Code	Title	Description
2011-08-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20004186D0 (no)	2000-08-22	Erythropoietin-liposomal dispersjon
MY111841A (en)	2001-01-31	Injectable liposomal pharmaceutical preparations
ATE308327T1 (de)	2005-11-15	Verwendung von 2-hydroxy-5-phenylazobenzoesäure- derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
EE9700146A (et)	1997-12-15	Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine
IT1281337B1 (it)	1998-02-18	Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
ATE301640T1 (de)	2005-08-15	Anellierte 4-carboxyamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp-hemmer
ATE178584T1 (de)	1999-04-15	Kationische lipide
ATE244015T1 (de)	2003-07-15	Formulierungen fuer faktor ix
BR9911013A (pt)	2001-02-06	Derivados de pirazol como inibidores da p-38 map quinase
HRP20010779B1 (hr)	2011-02-28	Farmaceutski pripravak
JPS6118718A (ja)	1986-01-27	抗炎症製薬組成物
DE60041976D1 (de)	2009-05-20	Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
KR970706021A (ko)	1997-11-03	N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
AU1438699A (en)	1999-06-16	Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
RU2000124317A (ru)	2002-08-20	Эритропоэтиновая липосомальная дисперсия
BR0009765B1 (pt)	2013-11-05	Compostos de ésteres de l-carnitina ou alcanoil l-carnitinase, uso dos mesmos, lipossomas contendo os referidos compostos e composições farmacêuticas e cosméticas contendo os ditos lipossomas.
CY1105318T1 (el)	2010-03-03	Φαρμακευτικες συνθεσεις για απο του στοματος και τοπικη χορηγηση
ATE287289T1 (de)	2005-02-15	Rückfettende ester auf basis von capryl-alkohol und isostearinsäure
KR960037677A (ko)	1996-11-19	4-인돌릴피페라지닐 유도체
BR9811954A (pt)	2000-08-22	ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
SE9604193L (sv)	1998-05-16	Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav
DE60035613D1 (de)	2007-08-30	Topische kosmetische und pharmazeutische Mittel enthaltend spezifische alkoxilierte Diester der Fumarsäure
DE69824855D1 (de)	2004-08-05	Macrozyklische laktone, zusammensetzungen und verfahren zur verwendung
ES2180065T3 (es)	2003-02-01	Formulaciones de uso topico que contienen acetato de vitamina e.
ATE227509T1 (de)	2002-11-15	Inhibitor- und konservierungsmittelzusammensetzung